Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

PharmaTher Holdings Ltd. PHRRF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score
52/100
2/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

PharmaTher Holdings Ltd. (PHRRF) is a Biotechnology company in the Healthcare sector, currently trading at $0.05. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Net income is $2M (loss), growing at +14.2%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $973,544 equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 3.11 (strong liquidity). Debt-to-assets is 0%. Total assets: $1M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 80/100 (Pass), Past 0/100 (Fail), Health 100/100 (Pass), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

PHRRF SharesGrow Score Overview

69/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 80/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — PHRRF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
80/100
PHRRF: +0%/yr revenue is, +14.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
100/100
Balance sheet PHRRF: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 3.11 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
PHRRF: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.0396-0.55
Volume53K
Avg Volume (30D)135.09K
Market Cap$4.28M
Beta (1Y)2.72
Share Statistics
EPS (TTM)-0.02
Shares Outstanding$76.31M
IPO Date2021-01-08
CEOFabio Chianelli
Financial Highlights & Ratios
EBITDA$-1.52M
Net Income$-1.53M
Operating Income$-1.52M
Total Cash$1.12M
Net Debt$-923.21K
Total Assets$1.34M
Price / Earnings (P/E)-2.7
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA71716H1082

Price Chart

Track all markets on TradingView
PHRRF
PharmaTher Holdings Ltd. ↗  ·  Other OTC
Healthcare • Biotechnology
0.04 52WK RANGE 0.55

People Also View

GHRS
GHRS
GH Research PLC
$16.77
+2.63%
 CKPT
CKPT
Checkpoint Therapeutics, Inc.
$4.26
+0.00%
 XOMAO
XOMAO
XOMA Corporation
$25.85
+1.49%
 FBIO
FBIO
Fortress Biotech, Inc.
$2.42
+0.00%
 LUMO
LUMO
Lumos Pharma, Inc.
$4.34
+0.00%
 ZIVO
ZIVO
ZIVO Bioscience, Inc.
$2.12
-3.64%
 RNAZ
RNAZ
TransCode Therapeutics, Inc.
$8.90
+1.14%
 TRYPF
TRYPF
Tryp Therapeutics Inc.
$0.06
+32.24%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message